01—Abstract
Summary
Summary of the 8-K filed June 8, 2006. Cited figures are marked; the original filing is the authoritative source.
This 8-K filing from Procter & Gamble (PG) on June 7, 2006, serves as a Regulation FD disclosure, primarily confirming the company's previously issued sales and earnings guidance for the fourth quarter of fiscal year 2005/06 (April-June).
The company reiterated its expectation of strong sales growth in the range of 20% to 24% and diluted earnings per share between $0.52a and $0.54. Investors are provided with the confirmed financial outlook for the upcoming quarter and the fiscal year.
The filing also highlights the scheduled release date for the final results, August 2, 2006, allowing investors to mark their calendars. While reiterating positive guidance, the company also includes a standard forward-looking statements disclaimer, outlining various risks and uncertainties that could impact actual results, including integration of key acquisitions like Gillette and Wella, competitive pressures, and currency fluctuations.
02—Key points
Key Highlights
- Procter & Gamble confirmed its sales and earnings guidance for the April-June quarter of FY 2005/06.
- Expected sales growth for the quarter is between 20% and 24%.
- Diluted earnings per share guidance for the quarter remains in the range of $0.52 to $0.54.
- The company anticipates that the components of its guidance will remain within previously disclosed ranges.
- Final results for the April-June quarter and the full fiscal year 2005/06 are scheduled for release on August 2, 2006.
- The filing reiterates standard forward-looking statements and potential risk factors, including integration of the Gillette and Wella acquisitions.
03—Questions
Frequently Asked Questions
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to serve as a Regulation FD disclosure, confirming Procter & Gamble's previously announced sales and earnings guidance for the fourth quarter of fiscal year 2005/06 and reiterating that the key components of this guidance are expected to remain in line with earlier announcements.
What are Procter & Gamble's sales and earnings expectations for the April-June 2006 quarter?
For the April to June quarter of fiscal year 2005/06, Procter & Gamble continues to expect sales growth in the range of 20% to 24% and diluted earnings per share between $0.52 and $0.54.
When will investors be able to see the final results for the quarter and the full fiscal year?
The company has scheduled the release of final results for the April to June quarter and for the entire fiscal year 2005/06 for August 2, 2006.
Does this filing mention any specific risks or challenges facing the company?
Yes, the filing includes a standard disclaimer of forward-looking statements that outlines various potential risks and uncertainties. These include the ability to successfully integrate major acquisitions like Gillette and Wella, manage competitive activity, navigate currency fluctuations, and achieve cost improvement plans.
04—Continue